Literature DB >> 32023164

Palliative and End-of-Life Care for Patients With Hematologic Malignancies.

Areej El-Jawahri1,2, Ashley M Nelson1,2, Tamryn F Gray2,3, Stephanie J Lee4, Thomas W LeBlanc5.   

Abstract

Hematologic malignancies are a heterogeneous group of diseases with unique illness trajectories, treatment paradigms, and potential for curability, which affect patients' palliative and end-of-life care needs. Patients with hematologic malignancies endure immense physical and psychological symptoms because of both their illness and often intensive treatments that result in significant toxicities and adverse effects. Compared with patients with solid tumors, those with hematologic malignancies also experience high rates of hospitalizations, intensive care unit admissions, and in-hospital deaths and low rates of referral to hospice as well as shorter hospice length of stay. In addition, patients with hematologic malignancies harbor substantial misperceptions about treatment risks and benefits and frequently overestimate their prognosis. Even survivors of hematologic malignancies struggle with late effects, post-treatment complications, and post-traumatic stress symptoms that can significantly diminish their quality of life. Despite these substantial unmet needs, specialty palliative care services are infrequently consulted for the care of patients with hematologic malignancies. Several illness-specific, cultural, and system-based barriers to palliative care integration and optimal end-of-life care exist in this population. However, recent evidence has demonstrated the feasibility, acceptability, and efficacy of integrating palliative care to improve the quality of life and care of patients with hematologic malignancies and their caregivers. More research is needed to develop and test population-specific palliative and supportive care interventions to ensure generalizability and to define a sustainable clinical delivery model. Future work also should focus on identifying moderators and mediators of the effect of integrated palliative care models on patient-reported outcomes and on developing less resource-intensive integrated care models to address the diverse needs of this population.

Entities:  

Mesh:

Year:  2020        PMID: 32023164     DOI: 10.1200/JCO.18.02386

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

1.  Barriers to seeking psychosocial support among adult patients with hematologic neoplasms: a qualitative study.

Authors:  Mengting Xie; Chunfeng Wang; Jingyi Chen; Ying Wang; Xiaoxia Wu; Yong Wu; Rong Hu
Journal:  Support Care Cancer       Date:  2021-11-23       Impact factor: 3.603

2.  The Efficacy of Hospice Care for Terminally Ill Emergency Patients During the Coronavirus 2019 Pandemic.

Authors:  Qing-Ling Wang; Bin-Ru Han; Peng Yue
Journal:  J Multidiscip Healthc       Date:  2022-08-04

3.  Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.

Authors:  Ashley M Nelson; Hermioni L Amonoo; Alison R Kavanaugh; Jason A Webb; Vicki A Jackson; Julia Rice; Mitchell W Lavoie; Amir T Fathi; Andrew M Brunner; Joseph A Greer; Jennifer S Temel; Areej El-Jawahri; Thomas W LeBlanc
Journal:  Cancer       Date:  2021-08-30       Impact factor: 6.921

Review 4.  Peer support in patients with hematologic malignancies: a systematic review.

Authors:  Hermioni L Amonoo; Lauren E Harnedy; Sophie C Staton; Regina M Longley; Elizabeth Daskalakis; Areej El-Jawahri; Jeff C Huffman
Journal:  Bone Marrow Transplant       Date:  2022-05-21       Impact factor: 5.174

5.  Ultrasound-guided microwave ablation as a palliative treatment for mycosis fungoides eyelid involvement: A case report.

Authors:  Yan-Wei Chen; Hai-Zhen Yang; Shuang-Shuang Zhao; Zheng Zhang; Zhe-Ming Chen; Hua-Hui Feng; Mao-Hui An; Ke-Ke Wang; Ran Duan; Bao-Ding Chen
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

6.  End-of-Life Care for Older Adults with Aggressive Non-Hodgkin Lymphoma.

Authors:  P Connor Johnson; Netana H Markovitz; Alisha Yi; Richard A Newcomb; Hermioni L Amonoo; Ashley M Nelson; Matthew J Reynolds; Julia Rice; Mitchell W Lavoie; Oreofe O Odejide; Ryan D Nipp; Areej El-Jawahri
Journal:  J Palliat Med       Date:  2021-11-01       Impact factor: 2.947

7.  One Size Does Not Fit All: The Need for Population-Specific Palliative Care Interventions.

Authors:  Jessica Bauman; Areej El-Jawahri
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

Review 8.  What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?

Authors:  Steffen T Simon; Anne Pralong; Michael Hallek; Christoph Scheid; Udo Holtick; Marco Herling
Journal:  Ann Hematol       Date:  2021-05-06       Impact factor: 3.673

Review 9.  Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients.

Authors:  Mengyang Di; Scott F Huntington; Adam J Olszewski
Journal:  Oncologist       Date:  2020-12-09       Impact factor: 5.837

10.  Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study.

Authors:  Vinay B Rao; Emmanuelle Belanger; Pamela C Egan; Thomas W LeBlanc; Adam J Olszewski
Journal:  J Palliat Med       Date:  2020-06-29       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.